
Event Description
For more than two decades, the Asian Venous Forum (AsVF) has held its annual meetings in collaboration with the Asian Society for Vascular Surgery, with programs carefully tailored to the diverse healthcare environments across Asia.
In 2026, AsVF will take an important new step forward.
For the first time, an independent, phlebology-focused academic meeting will be organized in Asia, held in conjunction with the 46th Annual Meeting of the Japanese Society of Phlebology.
This transition reflects not only an evolution in meeting structure, but also a broader shift in how venous medicine is developing across the region.
From Joint Sessions to an Independent Phlebology Forum
Historically, phlebology in Asia has often been discussed within broader vascular surgery or general vascular meetings. However, rapid advances in venous disease management, minimally invasive therapies, and hemodynamic understanding have highlighted the need for a more focused and dedicated academic platform.
With the support of former and current AsVF leadership, as well as the Japanese Society of Phlebology, Asian Venous Forum 2026 marks a milestone by establishing a dedicated venue for in-depth discussion of venous medicine in the Asian context.
Key Themes and Academic Focus
According to the organizing committee, phlebology is currently experiencing a wave of innovation—while simultaneously facing real-world constraints. The meeting will address several critical issues, including:
Advances in venous disease management and treatment strategies
The refinement of knowledge and contribution to emerging technologies
The need for sustainable and accessible treatment options, particularly relevant in Asia
Challenges related to limited healthcare budgets and restricted access to medications and devices
Regional diversity in healthcare systems, patient populations, and resource allocation
Through active interaction among participants, the meeting aims to promote knowledge exchange, enhance clinical practice, and stimulate future research.
Asian Venous Academy Perspective
The Asian Venous Academy (AVA) will continue to follow the academic developments of Asian Venous Forum 2026 and share key insights and updates before and after the meeting.
As venous medicine moves toward greater precision, long-term outcome awareness, and methodological depth, independent phlebology-focused academic forums rooted in Asian realities are becoming increasingly important.
Further updates and academic highlights will be shared by the Asian Venous Academy in due course.
- Theme: Innovation and Sustainability in Phlebology
Date: Friday, July 3, 2026
Venue: Korase Fukushima & Fukushima Green Palace, Fukushima, Japan - Congress President:
Tomohiro Ogawa, MD, PhD
Director, Fukushima Daiichi Hospital - Administrative Office:
Cardiovascular Disease Center, Fukushima Daiichi Hospital
16-2 Kitasawamata Nariide, Fukushima, Japan
Contact: venous@daiichihosp.jp - Official Website: https://asvf2026.com

Tomohiro Ogawa, MD, PhD
Congress Chairman, Asian Venous Forum & Japanese Society of Phlebology in Fukushima Vice President, Asian Venous Forum
Vice President, Japanese Society of Phlebology
Director, Fukushima Daiichi Hospital, Fukushima, Japan
Dear Distinguished Members of AsVF and Honored Guests,
We are pleased to announce a new format for the Asian Venous Forum (AsVF), designed for all professionals interested in phlebology, especially our colleagues across Asia.
For over 20 years, the annual AsVF meetings have been held in collaboration with the Asian Society for Vascular Surgery, tailored to the unique healthcare environments of our region. This year, we are taking on the exciting challenge of hosting an independent phlebology-focused meeting in Asia.
Thanks to the generous support of former AsVF President Prof. Takehisa Iwai, Japanese Society of Phlebology President Dr. Makoto Mo, and the executive committee—especially current AsVF President Prof. Sriram Narayan—we are able to organize this event in conjunction with the annual meeting of the Japanese Society of Phlebology.
Phlebology is undergoing a wave of innovation in both disease management and treatment. It is essential that we refine our knowledge and contribute to the development of new technologies. At the same time, we must address the need for sustainable and accessible treatment options, especially in the context of Asia’s unique challenges, such as limited healthcare budgets and restricted access to medications.
We hope this meeting will foster the exchange of knowledge, enhance clinical practice, and inspire research through vibrant interaction among members.
The venue will be in central Fukushima City, just 90 minutes from Tokyo via direct bullet train. Fukushima offers beautiful natural scenery, fresh air, rich historical sites, delicious cuisine, and relaxing hot springs—experiences that are hard to find in the hustle and bustle of urban life.
We are confident that your time in Fukushima will be both refreshing and enriching, and we look forward to welcoming you to the Asian Venous Forum on July 3rd.
With warm regards,

